近年来,世界己内酰胺生产能力稳步增长,2011年底,已超过540万吨。亚洲地区己内酰胺需求量增长迅猛,其中中国大陆和中国台湾是世界最大的己内酰胺进口国和地区。国内己内酰胺产能不断投建,预计2013年初我国己内酰胺年产能将突破100万吨/年,竞争加剧。在全球经济放缓的大环境下,国内己内酰胺原料价格上涨、新产能集中释放的同时,己内酰胺利润呈现萎缩态势。目前,国内己内酰胺市场深陷窘境,未来或将延续下跌行情。 In recent years, the world’s caprolactam production capacity has steadily increased by the end of 2011, has exceeded 5.4 million tons. Caprolactam demand in Asia is growing rapidly, with China and Taiwan being the largest importing countries and regions of caprolactam in the world. Caprolactam production capacity continues to cast into construction, is expected in early 2013 caprolactam annual capacity will exceed 1 million tons / year, increasing competition. In the global economic slowdown, the domestic caprolactam raw material prices, the concentration of new production capacity released at the same time, caprolactam profits showed shrinking trend. At present, the domestic caprolactam market dilemma, or will continue to decline in the future.